Gentherm Inc has received FDA 510(k) clearance for its ThermAffyx™ Patient Safety System, a Class II medical device that integrates active patient warming and securement in one platform. Designed specifically for robotic-assisted surgeries, this system addresses challenges like patient hypothermia and movement during procedures, especially in Trendelenburg position. Trials will start in August 2026, with commercial sales expected in Q3 2026, marking a significant expansion in Gentherm's medical product line focused on patient temperature management.
On August 17, Ripple minted 10 million RLUSD stablecoins on the XRP Ledger, increasing the circulating supply to approximately 1.711 billion tokens with a market cap near $1.71 billion. This minting confirms token issuance but does not prove immediat...
Bitcoin rose above $64,000 during Asian trading despite a nearly 3% weekly decline, with most major cryptocurrencies also down except Hyperliquid's HYPE token, which gained 9% weekly. The U.S. dollar weakened, influenced by disappointing retail sales...
Solana (SOL) price stabilizes around $75.55, supported by seven weeks of positive ETF inflows totaling $10.26 million last week, signaling sustained institutional interest. The token faces critical resistance between $78 and $80, which it must surpas...
In Q2 2026, Tron surpassed Ethereum to become the largest host of Tether's USDT stablecoin, growing its market cap to $89.2 billion. The blockchain's gasless transaction feature boosted adoption in emerging markets, enabling Tron to capture 52% of gl...
Bitcoin has recently broken above a six-day downtrend and is gaining momentum, with analysts hopeful it could surpass $65,000 this week. However, many investors are rotating back into gold, both in traditional and tokenized forms, which has limited B...
